TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Eql Pharma AB
Closing information (x1000 EUR)
Closing information | 2023/03 (consolidated) | 2022/03 (consolidated) | 2021/03 (consolidated) |
Turnover | 39,634 | 17,498 | |
Financial expenses | 278 | 98 | |
Earnings before taxes | 3,479 | 1,020 | |
EBITDA | 4,354 | 2,805 | |
Total assets | 23,010 | 19,421 | |
Current assets | 11,941 | 9,566 | |
Current liabilities | 9,552 | 9,273 | |
Equity capital | 11,958 | 8,918 | |
- share capital | 127 | 128 | |
Employees (average) | 18 | 13 | 10 |
Financial ratios
Fiscal year | 2023/03 (consolidated) | 2022/03 (consolidated) | 2021/03 (consolidated) |
Solvency | 52.0% | 45.9% | |
Turnover per employee | 3,049 | 1,750 | |
Profit as a percentage of turnover | 8.8% | 5.8% | |
Return on assets (ROA) | 16.3% | 5.8% | |
Current ratio | 125.0% | 103.2% | |
Return on equity (ROE) | 29.1% | 11.4% | |
Change turnover | 22,306 | 10,463 | |
Change turnover % | -37% | 129% | 149% |
Chg. No. of employees | 5 | 3 | 2 |
Chg. No. of employees % | 38% | 30% | 25% |
Total value of public sale
Fiscal year | 2023/03 (consolidated) | 2022/03 (consolidated) | 2021/03 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.